Skip to content
Sunday, November 15, 2026
Explore cutting-edge tech innovations and business strategi…

Zimbabwe Turns Down ‘One-Sided’ US Healthcare Assistance Agreement Due to Data Concerns

Medical aid image
The offered American funding would have supported programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has turned down a major American healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's demand for sensitive data.

The decision came to light after a official document dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "unbalanced".

An official representative later explained that the US was requesting health data for scientific study and commercial gain but was not willing to guarantee the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for further negotiations to find a deal agreeable to both sides so the country's critical HIV programme can proceed.

Broader Context

This development comes after a comparable situation in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were filed about the security of citizens' medical information.

Since returning to office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had administered aid for the American government, but Trump stated its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and accountability.

According to statements, Sixteen nations in Africa have so far agreed to these new health pacts, representing over $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through American-funded initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information for a long time, without any equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," his statement read.

"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our citizens should a future disease outbreak emerge."

Sovereignty and Global Health

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems previously established via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.

"This system is intended to guarantee that when a nation provides its information, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.

"We welcome continued dialogue with our US partners on how future collaboration could be designed in a way that respects the independence and interests of each country."

Health Experts Reaction

A leading public health body stated it understood the official position, but urged that talks should continue since a large portion of the nation's Aids initiatives relied on external financing.

"If technical issues arise, such as those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," the group commented.

The halted deal highlights the continuing challenges between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.

About the author

Joshua Dyer

A tech strategist and writer with over a decade of experience in digital transformation and startup ecosystems.

RapidCorner

Type to search articles.